SEBI OKs amendments to specify timeline to deploy NFO funds
This story was originally published at 06:00 IST on 19 December 2024
Register to read our real-time news.Informist, Wednesday, Dec. 18, 2024
MUMBAI – The board of Securities and Exchange Board of India Wednesday approved amendments to specify timelines for deployment of funds collected by mutual funds in new fund offers, as per the specified asset allocation of a scheme, it said in a press release today.
"The objective of the framework is to provide a timeline within which the fund manager would be required to deploy the funds garnered in an NFO as per the required asset allocation of the scheme. The new framework is aimed at encouraging AMCs (asset management companies) to collect only as much funds in NFOs as can be deployed in a reasonable period of time (i.e. ordinarily 30 days), since in the open-ended funds investors always have the option to enter the scheme ata later date at the prevailing NAV (net asset value)," the release said.
The framework also provides an option to investors to exit the scheme without paying an exit load in case the fund manager is unable to deploy the fund within the specified timeline, the release said. It also said that to address the issues of possible mis-selling in these new schemes, for switch transactions, the distributor will be entitled to the lower of the two commissions offered under the two schemes of the switch transaction. End
Reported by Kshipra Petkar
Edited by Akul Nishant Akhoury
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2024. All rights reserved.
To read more please subscribe
